$1.23
0.076.03%
最終更新: Oct 13, 7:59 PM
$1.07
-0.09-7.76%
Benzinga
Benzinga
Benzinga
水曜日, 10 14
Benzinga
© 2026 Benzinga | All Rights Reserved
Scinai Immunotherapeutics (SCNI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | H1 '26 | H1 '25 | Q4 '24 | Q3 '24 | FY '25 |
|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||||
| Estimate | — | — | — | — | — |
| Actual | $-6.40 | $-40.00 | $-95.70 | $-84.00 | $-35.60 |
| Surprise | — | — | — | — | — |
| Revenue | |||||
| Estimate | — | — | — | — | — |
| Actual | $949000 | $773000 | $206000 | $168000 | $1.3M |
| Surprise | — | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 11, 2023 | $-1.20 | $-0.91 | -31.9 % |
| Q1 | May 15, 2023 | $-1.20 | $-0.73 | -64.4 % |
| Q4 | Apr 17, 2023 | $0 | $-0.10 | 100.0 % |
| Q3 | Nov 30, 2022 | $0.06 | $-0.10 | 160.0 % |